ATE111485T1 - Peptidbehandlung von hartnäckigen infektionskrankheiten. - Google Patents
Peptidbehandlung von hartnäckigen infektionskrankheiten.Info
- Publication number
- ATE111485T1 ATE111485T1 AT89301259T AT89301259T ATE111485T1 AT E111485 T1 ATE111485 T1 AT E111485T1 AT 89301259 T AT89301259 T AT 89301259T AT 89301259 T AT89301259 T AT 89301259T AT E111485 T1 ATE111485 T1 AT E111485T1
- Authority
- AT
- Austria
- Prior art keywords
- infectious diseases
- peptide treatment
- persistent infectious
- peptide compound
- host
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 208000035473 Communicable disease Diseases 0.000 title 1
- 230000002085 persistent effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 102000054766 genetic haplotypes Human genes 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15486288A | 1988-02-10 | 1988-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE111485T1 true ATE111485T1 (de) | 1994-09-15 |
Family
ID=22553124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89301259T ATE111485T1 (de) | 1988-02-10 | 1989-02-09 | Peptidbehandlung von hartnäckigen infektionskrankheiten. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0328390B1 (de) |
| JP (1) | JPH01301699A (de) |
| AT (1) | ATE111485T1 (de) |
| DE (1) | DE68918127D1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2650954B1 (fr) * | 1989-08-18 | 1992-02-28 | Pasteur Institut | Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida |
| US6080846A (en) * | 1989-08-18 | 2000-06-27 | Institut Pasteur | Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus |
| US5688914A (en) * | 1989-08-18 | 1997-11-18 | Institut Pasteur | Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus |
| CN103347892B (zh) | 2011-01-06 | 2016-11-02 | 比奥诺尔免疫有限公司 | 单体和多聚体免疫原性肽 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS256960B1 (en) * | 1985-11-16 | 1988-04-15 | Viktor Krchnak | Peptides with properties of antigenic determinants and method of their production |
| EP0261224B2 (de) * | 1986-03-24 | 2003-03-26 | Ortho Pharmaceutical Corporation | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung |
| EP0247557B1 (de) * | 1986-05-27 | 1994-04-20 | F. Hoffmann-La Roche Ag | HTLV-III(LAV)Decke-Peptide |
| NL8702403A (nl) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc. |
-
1989
- 1989-02-09 EP EP89301259A patent/EP0328390B1/de not_active Expired - Lifetime
- 1989-02-09 AT AT89301259T patent/ATE111485T1/de not_active IP Right Cessation
- 1989-02-09 JP JP1028799A patent/JPH01301699A/ja active Pending
- 1989-02-09 DE DE68918127T patent/DE68918127D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0328390A3 (en) | 1990-10-31 |
| EP0328390A2 (de) | 1989-08-16 |
| JPH01301699A (ja) | 1989-12-05 |
| EP0328390B1 (de) | 1994-09-14 |
| DE68918127D1 (de) | 1994-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0330359A3 (de) | Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| ATE130762T1 (de) | Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen. | |
| DK0835133T3 (da) | Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf | |
| ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
| NO951903D0 (no) | Terapeautisk anvendelse av chimeriske og radiomerkede antistoff mot humant B-lymfocyttbegrenset, differensierende antigen for behandling av B-celle lymfom | |
| DE3855869D1 (de) | Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern | |
| EP0726758A4 (de) | Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus | |
| ATE101648T1 (de) | Expression eines tumorspezifischen antigens eines rekombinanten virusvektors sowie dessen anwendung zur versorgenden oder heilenden behandlung des entsprechenden tumors. | |
| HU9301794D0 (en) | Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament | |
| KR890002547A (ko) | Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 | |
| OA09889A (en) | Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus. | |
| DE69007571D1 (de) | Peptidfragmente von HIV. | |
| ATE111485T1 (de) | Peptidbehandlung von hartnäckigen infektionskrankheiten. | |
| ATE115863T1 (de) | Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen. | |
| ATE122100T1 (de) | Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen. | |
| ATE132374T1 (de) | Verhütung und behandlung einer retrovirenkrankheit | |
| ATE108335T1 (de) | Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. | |
| DE69015314D1 (de) | Verwendung von adenylzyclase als vakzin gegen bordetella. | |
| DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
| FR2646607B1 (fr) | Anticorps monoclonaux anti-b2 microglobuline | |
| ATE64855T1 (de) | Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom. | |
| SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов | |
| IT8349430A0 (it) | Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |